Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DOCK4 KIF13B CDK16 RBM15 CAMKK1 MARK3 HJURP C19orf47 MPDZ CLASP2 ATAT1 ARHGEF17 RGS12 NUAK2 PANK2 CASKIN2 NHS KIF2A LIMCH1 MTCL1 RASSF8 PC RASAL2	1.44e-11	861	161	23	36931259
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	CDK16 RBM15 CAMKK1 MARK3 PKP4 KIAA1549 MPDZ CLASP2 MAP1S EIF4EBP1 KIF2A MTCL1 RASSF8 RASAL2	2.42e-08	446	161	14	24255178
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CABLES2 MARK3 MAN1C1 OBSCN RNF213 CLASP2 SRCIN1 WNT4 ATAT1 PLBD2 SFMBT2 NDUFS3 DNAH14 BICD1 KLHL29 ATXN2 PKP3 ACSF3 CAMKMT RPRD2 LIMCH1 TAF4 NRG3 MBD5 PCDH1	2.49e-08	1489	161	25	28611215
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	HTRA1 MARK3 PKP4 KIAA1549 CLASP2 SRCIN1 ARHGEF17 NDUFS3 NUAK2 GAS2L1 MAP1S C12orf50 PABPC3 KIF2A LIMCH1 UQCRFS1 FH ALDOA PC PCDH1 RASAL2 CNTN1 UQCRFS1P1	2.08e-07	1431	161	23	37142655
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	PHRF1 OBSCN KIAA1549 RNF213 SFMBT2 SEMA4G DNAH5	4.77e-07	101	161	7	10997877
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	CDK16 GAS2L1 ATXN2 CASKIN2 PKP3 LIMCH1 RASAL2	7.53e-07	108	161	7	19531213
Pubmed	Conserved molecular signatures of neurogenesis in the hippocampal subgranular zone of rodents and primates.	CDCA3 CLSTN3 PDE3A HJURP POLE4 ATAT1 RGS12 SEMA4G PTPRN TMEM65 DCHS1	1.60e-06	376	161	11	24154525
Pubmed	Developmental expression of Smoc1 and Smoc2 suggests potential roles in fetal gonad and reproductive tract differentiation.	WT1 WNT4 GLI1	1.14e-05	10	161	3	19842175
Pubmed	The interactome of intact mitochondria by cross-linking mass spectrometry provides evidence for coexisting respiratory supercomplexes.	OBSCN NDUFS3 ATXN2 GLS ACSF3 UQCRFS1 FH PC MTX1 UQCRFS1P1	1.27e-05	382	161	10	29222160
Pubmed	Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling.	UQCRFS1 UQCRFS1P1	2.13e-05	2	161	2	23415911
Pubmed	A mild impairment of mitochondrial electron transport has sex-specific effects on lifespan and aging in mice.	UQCRFS1 UQCRFS1P1	2.13e-05	2	161	2	22028811
Pubmed	Aromatic Residues {epsilon}Trp-55 and {delta}Trp-57 and the Activation of Acetylcholine Receptor Channels.	CHRND CHRNE	2.13e-05	2	161	2	19171937
Pubmed	Assignment of the gene (UQCRFS1) for the Rieske iron-sulfur protein subunit of the mitochondrial cytochrome bc1 complex to the 22q13 and 19q12-q13.1 regions of the human genome.	UQCRFS1 UQCRFS1P1	2.13e-05	2	161	2	8088805
Pubmed	Cells lacking Rieske iron-sulfur protein have a reactive oxygen species-associated decrease in respiratory complexes I and IV.	UQCRFS1 UQCRFS1P1	2.13e-05	2	161	2	22106410
Pubmed	A 3' UTR modification of the mitochondrial rieske iron sulfur protein in mice produces a specific skin pigmentation phenotype.	UQCRFS1 UQCRFS1P1	2.13e-05	2	161	2	18401429
Pubmed	The receptor tyrosine kinase regulator Sprouty1 is a target of the tumor suppressor WT1 and important for kidney development.	SPRY1 WT1	2.13e-05	2	161	2	12882970
Pubmed	The adrenal capsule is a signaling center controlling cell renewal and zonation through Rspo3.	WT1 WNT4 GLI1	2.69e-05	13	161	3	27313319
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF13B PKP4 MPDZ CLASP2 GRIN2D ATXN2 PABPC3 DCHS1 KIF2A LIMCH1 MTCL1 TAF4 PCDH8 RASAL2 CNTN1	4.48e-05	963	161	15	28671696
Pubmed	Kif3a controls murine nephron number via GLI3 repressor, cell survival, and gene expression in a lineage-specific manner.	WT1 WNT4 GLI1	5.22e-05	16	161	3	23762375
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ZNF48 C19orf47 OBSCN CLASP2 FAM110A GRIN2D MXRA7 PRR12 GAS2L1 MAP1S GLI1 CSPG4 DOT1L SNAPC4 MBD5 PC	5.88e-05	1105	161	16	35748872
Pubmed	Superoxide generated at mitochondrial complex III triggers acute responses to hypoxia in the pulmonary circulation.	UQCRFS1 UQCRFS1P1	6.37e-05	3	161	2	23328522
Pubmed	A defect in the mitochondrial complex III, but not complex IV, triggers early ROS-dependent damage in defined brain regions.	UQCRFS1 UQCRFS1P1	6.37e-05	3	161	2	22914734
Pubmed	The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2.	MPDZ CSPG4	6.37e-05	3	161	2	10967549
Pubmed	Methylation Status of Transcriptional Modulatory Genes Associated with Colorectal Cancer in Northeast China.	WT1 CSPG4	6.37e-05	3	161	2	29291617
Pubmed	Efferocytosis Fuels Requirements of Fatty Acid Oxidation and the Electron Transport Chain to Polarize Macrophages for Tissue Repair.	UQCRFS1 UQCRFS1P1	6.37e-05	3	161	2	30595481
Pubmed	TTC19 Plays a Husbandry Role on UQCRFS1 Turnover in the Biogenesis of Mitochondrial Respiratory Complex III.	UQCRFS1 UQCRFS1P1	6.37e-05	3	161	2	28673544
Pubmed	Oxygen regulation of breathing is abolished in mitochondrial complex III-deficient arterial chemoreceptors.	UQCRFS1 UQCRFS1P1	6.37e-05	3	161	2	36122208
Pubmed	Rapsyn carboxyl terminal domains mediate muscle specific kinase-induced phosphorylation of the muscle acetylcholine receptor.	CHRND CHRNE	6.37e-05	3	161	2	18436384
Pubmed	Changes in mRNA expression of nicotinic acetylcholine receptor subunits during embryonic development of mouse masseter muscle.	CHRND CHRNE	6.37e-05	3	161	2	12012784
Pubmed	A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis.	DOCK4 CSPG4	6.37e-05	3	161	2	26129894
Pubmed	Ubiquitin specific peptidase 49 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.	USP49 PIK3R2	6.37e-05	3	161	2	31001918
Pubmed	WT1 and Sox11 regulate synergistically the promoter of the Wnt4 gene that encodes a critical signal for nephrogenesis.	WT1 WNT4	6.37e-05	3	161	2	22465478
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	CDCA3 MARK3 PKP4 FAM110A SRCIN1 CASKIN2 PKP3 NHS LIMCH1 ALDOA PCDH1	7.02e-05	565	161	11	25468996
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	RBM15 MARK3 MATN2 PKP4 CLASP2 NDUFS3 PIK3R2 CHTF18 PKP3 NHS KIF2A LIMCH1 UQCRFS1 RASSF8 DOT1L FH ALDOA	7.18e-05	1247	161	17	27684187
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	CDCA3 KIF13B MARK3 PKP4 KIAA1549 RGS12 BICD1 CASKIN2 CSPG4 PCDH1 RASAL2	7.47e-05	569	161	11	30639242
Pubmed	A BMP-controlled metabolic/epigenetic signaling cascade directs midfacial morphogenesis.	SPRY1 IFT88 GLI1 ALDOA	1.09e-04	53	161	4	38466355
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	CDCA3 ZSWIM8 CLSTN3 ZNF48 MARK3 PKP4 DNAH14 ICMT CASKIN2 CHTF18 PKP3 LIMCH1 ALDOA TAP2	1.10e-04	925	161	14	28986522
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	DPYD RBM15 OBSCN CLASP2 SRCIN1 RGS12 MAP1S KIF2A LIMCH1 TAF4	1.15e-04	497	161	10	36774506
Pubmed	Hedgehog-GLI signaling in Foxd1-positive stromal cells promotes murine nephrogenesis via TGFβ signaling.	WT1 WNT4 GLI1	1.22e-04	21	161	3	29945868
Pubmed	Single cell transcriptomics identifies a signaling network coordinating endoderm and mesoderm diversification during foregut organogenesis.	WT1 WNT4 GLI1	1.22e-04	21	161	3	32855417
Pubmed	The DNA sequence of the human X chromosome.	CDK16 ZC3H12B BEND2 RAB41 GPC4 NHS ATP11C KLHL34 VGLL1	1.26e-04	407	161	9	15772651
Pubmed	Function of interfacial prolines at the transmitter-binding sites of the neuromuscular acetylcholine receptor.	CHRND CHRNE	1.27e-04	4	161	2	23519471
Pubmed	Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice.	WT1 WNT4	1.27e-04	4	161	2	26035382
Pubmed	Design and control of acetylcholine receptor conformational change.	CHRND CHRNE	1.27e-04	4	161	2	21368211
Pubmed	Acetylcholine receptor assembly: subunit folding and oligomerization occur sequentially.	CHRND CHRNE	1.27e-04	4	161	2	8334706
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	OBSCN RNF213	1.27e-04	4	161	2	26147384
Pubmed	Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies.	UQCRFS1 UQCRFS1P1	1.27e-04	4	161	2	21278747
Pubmed	New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome.	CHRND CHRNE	1.27e-04	4	161	2	8872460
Pubmed	Mutation of single murine acetylcholine receptor subunits reveals differential contribution of P121 to acetylcholine binding and channel opening.	CHRND CHRNE	1.27e-04	4	161	2	15864502
Pubmed	Developmental changes in the nicotinic acetylcholine receptor in mouse tongue striated muscle.	CHRND CHRNE	1.27e-04	4	161	2	11926244
Pubmed	SOGA1 and SOGA2/MTCL1 are CLASP-interacting proteins required for faithful chromosome segregation in human cells.	CLASP2 MTCL1	1.27e-04	4	161	2	33587225
Pubmed	The local anaesthetics proadifen and adiphenine inhibit nicotinic receptors by different molecular mechanisms.	CHRND CHRNE	1.27e-04	4	161	2	19422391
Pubmed	Compensatory elevation of voluntary activity in mouse mutants with impaired mitochondrial energy metabolism.	UQCRFS1 UQCRFS1P1	1.27e-04	4	161	2	25413331
Pubmed	Ceramides modulate cell-surface acetylcholine receptor levels.	CHRND CHRNE	1.27e-04	4	161	2	18023270
Pubmed	ALDOA coordinates PDE3A through the β-catenin/ID3 axis to stimulate cancer metastasis and M2 polarization in lung cancer with EGFR mutations.	PDE3A ALDOA	1.27e-04	4	161	2	38244313
Pubmed	The mitochondrial respiratory chain is essential for haematopoietic stem cell function.	UQCRFS1 UQCRFS1P1	1.27e-04	4	161	2	28504706
Pubmed	Progesterone induced mesenchymal differentiation and rescued cystic dilation of renal tubules of Pkd1(-/-) mice.	WT1 WNT4	1.27e-04	4	161	2	22835934
Pubmed	The ultrastructural localization and quantitation of cholinergic receptors at the mouse motor endplate.	CHRND CHRNE	1.27e-04	4	161	2	4781450
Pubmed	Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.	SRCIN1 PABPC3	1.27e-04	4	161	2	24129315
Pubmed	ATXN2-CAG42 sequesters PABPC1 into insolubility and induces FBXW8 in cerebellum of old ataxic knock-in mice.	ATXN2 PABPC3	1.27e-04	4	161	2	22956915
Pubmed	MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.	MARK3 CLASP2 MAP1S KIF2A	1.44e-04	57	161	4	29089450
Pubmed	The G protein-coupled receptor Gpr161 regulates forelimb formation, limb patterning and skeletal morphogenesis in a primary cilium-dependent manner.	RBL2 IFT88 GLI1	1.61e-04	23	161	3	29222391
Pubmed	Primary cilia in murine palatal rugae development.	WNT4 IFT88 GLI1	1.61e-04	23	161	3	31226309
Pubmed	Chemical Crosslinking Mass Spectrometry Analysis of Protein Conformations and Supercomplexes in Heart Tissue.	OBSCN NDUFS3 GLS UQCRFS1 FH ALDOA DNAH5 UQCRFS1P1	1.65e-04	331	161	8	29199018
Pubmed	Proteomics strategy to identify substrates of LNX, a PDZ domain-containing E3 ubiquitin ligase.	PKP4 PTGIR GPR142 SDK1	1.76e-04	60	161	4	22889411
Pubmed	Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions.	SRCIN1 NDUFS3 UQCRFS1 ALDOA CNTN1 UQCRFS1P1	1.78e-04	176	161	6	18614564
Pubmed	Atmin mediates kidney morphogenesis by modulating Wnt signaling.	WNT4 IFT88 GLI1	1.83e-04	24	161	3	24852369
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	DOCK4 CAMKK1 MARK3 RGS12 PIK3R2 RASSF8 RASAL2	1.96e-04	255	161	7	15324660
Pubmed	Steroidogenic differentiation and PKA signaling are programmed by histone methyltransferase EZH2 in the adrenal cortex.	PDE3A WT1 GLI1	2.08e-04	25	161	3	30541888
Pubmed	Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.	IFT88 GLI1 DNAH5	2.08e-04	25	161	3	27340223
Pubmed	AHR regulates WT1 genetic programming during murine nephrogenesis.	WT1 WNT4	2.11e-04	5	161	2	21863216
Pubmed	Origin and characterization of alpha smooth muscle actin-positive cells during murine lung development.	WT1 GLI1	2.11e-04	5	161	2	28370670
Pubmed	The Adult Adrenal Cortex Undergoes Rapid Tissue Renewal in a Sex-Specific Manner.	WNT4 GLI1	2.11e-04	5	161	2	31104943
Pubmed	Six1 and Six2 of the Sine Oculis Homeobox Subfamily are Not Functionally Interchangeable in Mouse Nephron Formation.	WT1 WNT4	2.11e-04	5	161	2	35178390
Pubmed	Properties of embryonic and adult muscle acetylcholine receptors transiently expressed in COS cells.	CHRND CHRNE	2.11e-04	5	161	2	2383398
Pubmed	Mitochondrial complex III is essential for suppressive function of regulatory T cells.	UQCRFS1 UQCRFS1P1	2.11e-04	5	161	2	30626970
Pubmed	Sprouty1 Controls Genitourinary Development via its N-Terminal Tyrosine.	SPRY1 WT1	2.11e-04	5	161	2	31300484
Pubmed	Periodic stripe formation by a Turing mechanism operating at growth zones in the mammalian palate.	SPRY1 GLI1	2.11e-04	5	161	2	22344222
Pubmed	RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma.	RBM15 C19orf47 NDUFS3 RPRD2 KIF2A FH	2.19e-04	183	161	6	28186131
Pubmed	Armc8 is an evolutionarily conserved armadillo protein involved in cell-cell adhesion complexes through multiple molecular interactions.	PKP4 PKP3	3.16e-04	6	161	2	30482882
Pubmed	Sonic Hedgehog and WNT Signaling Promote Adrenal Gland Regeneration in Male Mice.	WNT4 GLI1	3.16e-04	6	161	2	29211850
Pubmed	Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats.	ATXN2 GLS	3.16e-04	6	161	2	8896557
Pubmed	Ciliopathy Protein Tmem107 Plays Multiple Roles in Craniofacial Development.	IFT88 GLI1	3.16e-04	6	161	2	28954202
Pubmed	WT1 Disorder	WT1 GPC4	3.16e-04	6	161	2	32352694
Pubmed	Mammalian Fat and Dachsous cadherins regulate apical membrane organization in the embryonic cerebral cortex.	MPDZ DCHS1	3.16e-04	6	161	2	19506035
Pubmed	Derivation of lung mesenchymal lineages from the fetal mesothelium requires hedgehog signaling for mesothelial cell entry.	WT1 GLI1	3.16e-04	6	161	2	24130328
Pubmed	Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function.	IFT88 GLI1	3.16e-04	6	161	2	16254602
Pubmed	Identification of 14-3-3epsilon substrates from embryonic murine brain.	MARK3 SRCIN1 ATAT1 PANK2 PIK3R2	3.85e-04	132	161	5	16944949
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	DOCK4 SRCIN1 CASKIN2 GLS IRF2BPL RPRD2 MTCL1 TAF4 RASSF8 MBD5 RASAL2	3.89e-04	689	161	11	36543142
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	CDCA3 SPRY1 MARK3 PKP4 CASKIN2 CSPG4 PCDH1 RASAL2	3.94e-04	377	161	8	38117590
Pubmed	Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate.	WT1 WNT4 GLI1	3.98e-04	31	161	3	36362374
Pubmed	ZEB2 controls kidney stromal progenitor differentiation and inhibits abnormal myofibroblast expansion and kidney fibrosis.	WT1 GLI1 CSPG4	3.98e-04	31	161	3	36445780
Pubmed	Neuromuscular synapse formation in mice lacking motor neuron- and skeletal muscle-derived Neuregulin-1.	CHRND CHRNE	4.40e-04	7	161	2	16407563
Pubmed	Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4.	WT1 WNT4	4.40e-04	7	161	2	7990960
Pubmed	PAX6-Related Aniridia	WT1 GPC4	4.40e-04	7	161	2	20301534
Pubmed	A role for the calmodulin kinase II-related anchoring protein (αkap) in maintaining the stability of nicotinic acetylcholine receptors.	CHRND CHRNE	4.40e-04	7	161	2	22496563
Pubmed	Defects of urogenital development in mice lacking Emx2.	WT1 WNT4	4.40e-04	7	161	2	9165114
Pubmed	A novel murine allele of Intraflagellar Transport Protein 172 causes a syndrome including VACTERL-like features with hydrocephalus.	IFT88 GLI1	4.40e-04	7	161	2	21653639
Pubmed	Editing activity for eliminating mischarged tRNAs is essential in mammalian mitochondria.	UQCRFS1 UQCRFS1P1	4.40e-04	7	161	2	29228266
Pubmed	Calcium/NFAT signalling promotes early nephrogenesis.	WT1 WNT4	4.40e-04	7	161	2	21295565
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	LRFN3 OBSCN LINGO3 IGSF10 ALPK3 SDK1 CNTN1	2.92e-05	161	99	7	593
GeneFamily	Fibronectin type III domain containing	COL7A1 LRFN3 OBSCN USH2A SDK1 CNTN1	2.49e-04	160	99	6	555
GeneFamily	Non-clustered protocadherins	PCDH1 PCDH8	1.89e-03	12	99	2	21
GeneFamily	Potassium two pore domain channel subfamily K	KCNK4 KCNK15	2.98e-03	15	99	2	277
GeneFamily	Cholinergic receptors nicotinic subunits	CHRND CHRNE	3.39e-03	16	99	2	173
GeneFamily	Dyneins, axonemal	DNAH14 DNAH5	3.83e-03	17	99	2	536
GeneFamily	Cadherin related	CLSTN3 DCHS1	3.83e-03	17	99	2	24
GeneFamily	Immunoglobulin like domain containing	CEACAM7 SEMA4G ALPK3 SDK1 CNTN1	4.19e-03	193	99	5	594
GeneFamily	Proteases, serine	HTRA1 TMPRSS13 PRSS33	4.99e-03	63	99	3	738
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	RNF213 DNAH14 GLS NHS CAMKMT NRG3 MBD5 SDK1 RASAL2	1.36e-06	176	159	9	M39223
Coexpression	LIAO_METASTASIS	PKP4 HJURP PUSL1 FAM110A PLBD2 KLHL29 CHTF18 GLS TMEM65 ALPK3 KIF2A MTCL1 SNAPC4 ALDOA	5.75e-06	540	159	14	M13809
ToppCell	Neuronal-Inhibitory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PDE3A HTRA1 GRIN2D RGS12 SEMA4G NHS ATP11C RASSF8 SDK1	5.04e-08	200	161	9	9ff8647e2de0b538e15929dca88ebb20ff7ab043
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A PTGIR RGS12 ST8SIA6 NHS ATP11C NPW PCDH8	3.85e-07	185	161	8	79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 WNT4 GRIN2D RGS12 NHS PCDH8 SDK1	4.18e-07	187	161	8	ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRIN2D RGS12 ST8SIA6 NHS ATP11C RASSF8 PCDH8 SDK1	4.18e-07	187	161	8	02105c82a9ba79d2f19e002188377fc3440770c2
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 WNT4 GRIN2D RGS12 NHS PCDH8 SDK1	4.36e-07	188	161	8	6ee3f8f94ea7bdf652c9575fc65bff08070093a4
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	DOCK4 SPRY1 CLASP2 GFRA2 LIMCH1 MBD5 UTY CNTN1	4.72e-07	190	161	8	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 WNT4 GRIN2D RGS12 NHS PCDH8 SDK1	5.11e-07	192	161	8	6a252e298f8a454623fa9c1c893a7a45a886d694
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPRY1 PDE3A ARHGEF17 GFRA2 PDE8B CSPG4 GPC4 CNTN1	6.95e-07	200	161	8	cf883ba5dbe6350b93142d625a52b25ff2a8bb63
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PDE3A HTRA1 WNT4 GRIN2D RGS12 NHS PCDH8 SDK1	6.95e-07	200	161	8	7e51715525fdb001b7042b2bfcb9de81ecb5e4ee
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PDE3A GRIN2D RGS12 ST8SIA6 NHS ATP11C NPW SDK1	6.95e-07	200	161	8	53d5e427f0cbf5cf0b63efe4ec01da302f555704
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_only / Treatment groups by lineage, cell group, cell type	SPRY1 PDE3A ARHGEF17 GFRA2 PDE8B CSPG4 GPC4 CNTN1	6.95e-07	200	161	8	69edc375d85689300d1dbc1217fedc40063ecdcb
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	SPRY1 MATN2 ARHGEF17 GFRA2 PDE8B CSPG4 GPC4 CNTN1	6.95e-07	200	161	8	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PDE3A HTRA1 WNT4 GRIN2D RGS12 NHS PCDH8 SDK1	6.95e-07	200	161	8	75649534a98bc738fca62d071de0978dc61eb24f
ToppCell	COVID-19-kidney-REN+Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE3A ARHGEF17 PDE8B CSPG4 NHS ATP11C CNTN1	3.39e-06	174	161	7	8393f0b43c767839c1630bcb952d62b42efc788d
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A PTGIR RGS12 ST8SIA6 ATP11C RASSF8 PCDH8	3.94e-06	178	161	7	e86ed30652c2de70f16430f04b78789b87df4af2
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 GRIN2D NHS RASSF8 PCDH8 SDK1	4.08e-06	179	161	7	3b0f8781232e1d42b6f8913bc989a14b3f978e79
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_1\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PDE3A FAM110A BEND2 PTGIR GAS2L1 PTPRN TREML1	4.24e-06	180	161	7	3c605d6adb4199963532f3639f2c768f7e575152
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_1\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE3A FAM110A BEND2 PTGIR GAS2L1 PTPRN TREML1	4.24e-06	180	161	7	3d52ca0568f9c0d6359b302ff5ff41b075f78597
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 GRIN2D RGS12 KLHDC8A PCDH8 SDK1	4.39e-06	181	161	7	35bcdcd2651149692e5b150e887c0f450c81d2d4
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A RGS12 NHS ATP11C NPW PCDH8 SDK1	4.39e-06	181	161	7	2f3d04d22d4ac016e61709ea5af3d48885c946c4
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 WNT4 ARHGEF17 SEMA4G PDE8B CSPG4 GPC4	4.56e-06	182	161	7	9edaccf1154cec92ca9a28e9b1f9075cfd422bfd
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 WNT4 GRIN2D RGS12 NHS SDK1	4.56e-06	182	161	7	420a8fd30543e37a66ba0786215d056d308660d0
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 WNT4 ARHGEF17 SEMA4G PDE8B CSPG4 GPC4	4.56e-06	182	161	7	aba4c06d5d7618ac21b2695bca8e7a1346a91090
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 WNT4 GRIN2D RGS12 PCDH8 SDK1	4.90e-06	184	161	7	32473dbdb2de66391157c5814ef34e790806e4f2
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPRY1 PDE3A ARHGEF17 GFRA2 CSPG4 GPC4 CNTN1	4.90e-06	184	161	7	102b6f621a5b551e622f97b12d787c080b052a72
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A GRIN2D RGS12 NHS NPW PCDH8 SDK1	5.07e-06	185	161	7	487fa382232564f075960899d50afa0edae5d258
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 WNT4 GRIN2D RGS12 NHS PCDH8	5.07e-06	185	161	7	cefd81adb480c027545a5c78dcd05669783717f4
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PDE3A KIAA1549 ARHGEF17 CSPG4 ATP11C CNTN1	5.44e-06	187	161	7	15d6e158562d7d85af3ceaf955439b379c8fce81
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A RGS12 ST8SIA6 ATP11C NPW RASSF8 PCDH8	5.44e-06	187	161	7	d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PDE3A KIAA1549 ARHGEF17 CSPG4 ATP11C CNTN1	5.44e-06	187	161	7	f62074b631fd45ad299c69d71b09267b04d656ee
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 WNT4 GRIN2D RGS12 NHS PCDH8	5.64e-06	188	161	7	c66fccdfe68760b8c3efca77e3c25966dc9a8a5f
ToppCell	COPD-Myeloid-DC_Mature\|COPD / Disease state, Lineage and Cell class	PTGIR NUAK2 ATP11C KIF2A LIMCH1 TREML1 SDK1	5.64e-06	188	161	7	de93ccb53edb8599da9e312db0e3af604c21f673
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PDE3A KIAA1549 ARHGEF17 CSPG4 ATP11C CNTN1	5.64e-06	188	161	7	32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDE3A MATN2 WT1 PTGIR SFMBT2 KLHL29 NHS	6.04e-06	190	161	7	0fea33f2dc1efa23aaa2da1c318482a52a313ff1
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 WNT4 GRIN2D RGS12 NHS PCDH8	6.25e-06	191	161	7	06760c3bb40e4f66879a5f5e09c9abfce4ebbba3
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 GRIN2D RGS12 NHS PCDH8 SDK1	6.47e-06	192	161	7	3abee376c37c3646da33ac381aa63d50a01607a6
ToppCell	COPD-Myeloid-DC_Mature\|Myeloid / Disease state, Lineage and Cell class	PTGIR NUAK2 ATP11C KIF2A LIMCH1 TREML1 SDK1	6.47e-06	192	161	7	baebd462f464e7d0e462d07a74bb5d685a9fc3b6
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 GRIN2D RGS12 NHS PCDH8 SDK1	6.47e-06	192	161	7	025fac36b862f9ca7f96fb4a1946c44ba7cbc382
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 GRIN2D RGS12 SEMA4G NHS SDK1	6.47e-06	192	161	7	bf1943715085c4124b1675888b0615c9500ec888
ToppCell	normal_Lymph_Node-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	PTGIR NUAK2 GLS ATP11C KIF2A LIMCH1 TREML1	6.69e-06	193	161	7	024d30eb143d8278c0851c3a6c9426226fa3b480
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTRA1 MATN2 WT1 WNT4 PTGIR NPW PCDH8	7.91e-06	198	161	7	9541d68a1a6247dbd7161a62644eea6527c2c8ff
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	DOCK4 RBM15 PDE3A PTGIR GFRA2 MICALL2 LIMCH1	7.91e-06	198	161	7	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SPRY1 PDE3A HTRA1 ARHGEF17 FBXL22 CSPG4 MTCL1	7.91e-06	198	161	7	c9c96066c7fa897b583657f0b77ea093920ae9ba
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTRA1 MATN2 WT1 WNT4 PTGIR NPW CNTN1	8.17e-06	199	161	7	83383d9ae4f501754fd3da0215ce6f0e3c70562c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SPRY1 PDE3A ARHGEF17 GFRA2 PDE8B CSPG4 CNTN1	8.45e-06	200	161	7	b5b5a32925f225610fe25a021a742d6397162863
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SPRY1 ARHGEF17 GFRA2 PDE8B CSPG4 GPC4 CNTN1	8.45e-06	200	161	7	d2fcd3bd7c3223875f027eeb48ff621192a5f242
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SPRY1 PDE3A GPR143 ARHGEF17 GFRA2 CSPG4 GPC4	8.45e-06	200	161	7	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SPRY1 PDE3A ARHGEF17 GFRA2 PDE8B CSPG4 GPC4	8.45e-06	200	161	7	4e1e19214aeebbdca004de7faaf4cc9d18498591
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPRY1 PDE3A ARHGEF17 GFRA2 PDE8B CSPG4 GPC4	8.45e-06	200	161	7	b22cae282591d8dead9869c2adbb9632615f50f7
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GRIN2D RGS12 ST8SIA6 NHS ATP11C NPW RASSF8	8.45e-06	200	161	7	d0167f96314be78b6d867bbcc6e4396071d931b8
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PDE3A HTRA1 RGS12 ST8SIA6 ATP11C RASSF8 PCDH8	8.45e-06	200	161	7	8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1
ToppCell	Neuronal-Inhibitory-iA\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PDE3A HTRA1 GRIN2D RGS12 NHS ATP11C SDK1	8.45e-06	200	161	7	5ef4a3dc18a44292184a59ced916183c0699b01e
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PCDH20-L1-2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PDE3A HTRA1 GRIN2D RGS12 ST8SIA6 ATP11C PCDH8	8.45e-06	200	161	7	1d67c5d2c617749b521e70879950dea2c9d076d6
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SPRY1 PDE3A ARHGEF17 GFRA2 PDE8B CSPG4 GPC4	8.45e-06	200	161	7	786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SPRY1 PDE3A MATN2 ARHGEF17 GFRA2 CSPG4 GPC4	8.45e-06	200	161	7	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-CHRNA4-L1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GRIN2D RGS12 ST8SIA6 ATP11C NPW RASSF8 SDK1	8.45e-06	200	161	7	e2ced6eb1de9a526c34c7558b9c637854916e624
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte\|Control_saline / Treatment groups by lineage, cell group, cell type	SPRY1 PDE3A ARHGEF17 GFRA2 CSPG4 GPC4 CNTN1	8.45e-06	200	161	7	cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c
ToppCell	Influenza-Influenza_Severe-Others-Platelet\|Influenza_Severe / Disease, condition lineage and cell class	PDE3A BEND2 CHST8 GAS2L1 PTPRN KIF2A TREML1	8.45e-06	200	161	7	548e8e2f0e4225827db58b0c8b05221f18ae482b
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-CHRNA4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GRIN2D RGS12 ST8SIA6 ATP11C NPW RASSF8 SDK1	8.45e-06	200	161	7	9bc924755e5a4c464408e6103b86bf1b4e8c58b5
ToppCell	LPS_IL1RA-Mesenchymal_myocytic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPRY1 PDE3A ARHGEF17 GFRA2 PDE8B CSPG4 GPC4	8.45e-06	200	161	7	77631c471cc5d453a749784f838cfa6408caf09b
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PCDH20\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PDE3A HTRA1 GRIN2D RGS12 ST8SIA6 ATP11C PCDH8	8.45e-06	200	161	7	26c7f2b0afe9e50f2a5c43918ad8e91d7553b72c
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDE3A HTRA1 MXRA7 KCNK15 EIF4EBP1 PCDH8	1.21e-05	140	161	6	72c272f44e5600b3037c1dbf9d3a4669a35588d8
ToppCell	Children_(3_yrs)-Immune-mast_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDE3A KIAA1549 GPR143 FAM110A MTCL1 VGLL1	2.00e-05	153	161	6	d3fb83ca984c7583b1e51c364be6c7c17f67b048
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDE3A HTRA1 RGS12 MXRA7 LIMCH1 PCDH8	2.66e-05	161	161	6	be77e99faf653480c166305df3a4e93db76f0dcb
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAN1C1 PTGIR GLI1 CSNK1G2-AS1 KLHL34 CNTN1	2.76e-05	162	161	6	bfaeff19bb56598fdc8c82be71d51787cf13928f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A WT1 ARHGEF17 CSPG4 ATP11C CNTN1	2.96e-05	164	161	6	f6a961fa2002da7d9679f32af99e1314c0593ef9
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	ZNF619 PRR25 TTBK1 PTPRN C1orf216 DNAH5	3.06e-05	165	161	6	9795ce31689bc63f5a2d68725ef00b23a90c3846
ToppCell	368C-Myeloid-Dendritic-cDC_activated\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	COL7A1 NUAK2 PDE8B KIF2A PC TREML1	3.06e-05	165	161	6	9d2bdc42c13c8c2a68889bec8612a1ce56f659fa
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A WT1 ARHGEF17 CSPG4 EIF4EBP1 CNTN1	3.27e-05	167	161	6	b4ef07117d14da3d5fbced949e4dfcb01c392295
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A WT1 ARHGEF17 CSPG4 EIF4EBP1 CNTN1	3.27e-05	167	161	6	94fc7df7ca55cd722a8dbd153201a29891217473
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A WT1 ARHGEF17 CSPG4 EIF4EBP1 CNTN1	3.27e-05	167	161	6	eff3723fe60755272eca237459165e436e919ece
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MAN1C1 MATN2 WNT4 GFRA2 DNAH14 CHST8	3.38e-05	168	161	6	3fe432267656aff81b6d92c18d1b6fc0cde73d6a
ToppCell	severe-HSPC\|World / disease stage, cell group and cell class	SPRY1 PDE3A DNAH14 IGSF10 CASKIN2 NPW	3.50e-05	169	161	6	b0421b73bfdc92f7a2762b4b670b9eae124aa702
ToppCell	normal_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	OBSCN PDE8B CSPG4 GPC4 PCDH1 RASAL2	3.62e-05	170	161	6	d69c0ea4cb6b204f19d0a5d2164afb42184779ac
ToppCell	wk_20-22-Hematologic-Meg-ery-Megakaryocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MAFG PDE3A BEND2 PTGIR GAS2L1 TREML1	3.62e-05	170	161	6	eace4dd09cdbde0fa40a6aa0f3dba1114d0ce475
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTRA1 GRIN2D RGS12 ST8SIA6 ATP11C PCDH8	3.86e-05	172	161	6	35e961c88bfe79046533396912cedf00ca81db7b
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-hematologic-thrombocytic\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PDE3A BEND2 PTGIR GAS2L1 PTPRN TREML1	3.86e-05	172	161	6	1a9b99c7fc297d9e4b6098bf0c4fb98927a05f6d
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-hematologic-thrombocytic-platelet\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PDE3A BEND2 PTGIR GAS2L1 PTPRN TREML1	3.86e-05	172	161	6	d588ca825ab301910c1378e009b766c809b0bd5e
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL7A1 ZC3H12B KDM4D PDE8B PABPC3 KIF2A	3.86e-05	172	161	6	c6bc78fd63c9479a84ec0552b55c89750cad0fa5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A WT1 ARHGEF17 CSPG4 ATP11C CNTN1	3.86e-05	172	161	6	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL7A1 ZC3H12B KDM4D PDE8B PABPC3 KIF2A	3.86e-05	172	161	6	bfb87a281a9cf6ad45b310bf8104fc0ab382b549
ToppCell	cellseq-Immune-Hematopoietic-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FAM110A BEND2 CHST8 GAS2L1 KIF2A TREML1	3.86e-05	172	161	6	d0c3fb48c61762dcefca858cf13c9da8eb6d0f5e
ToppCell	Adult-Mesenchymal-pericyte_cell-D231\|Adult / Lineage, Cell type, age group and donor	SPRY1 PDE3A BEND2 ARHGEF17 CHRND CSPG4	3.86e-05	172	161	6	858cee96c1c06160863b4adcd7023c0d678bd50f
ToppCell	cellseq-Immune-Hematopoietic-Megakaryocyte/Platelet\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FAM110A BEND2 CHST8 GAS2L1 KIF2A TREML1	3.86e-05	172	161	6	eb2915165cab2660511e4b70c3a6d3ab2f770809
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A WT1 ARHGEF17 CSPG4 ATP11C CNTN1	3.86e-05	172	161	6	553701349444eb366df3c11f54bb093434f153c6
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDE3A HTRA1 RGS12 LIMCH1 PCDH8 SDK1	3.86e-05	172	161	6	7e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCell	PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CAMKK1 PTGIR GAS2L1 PTPRN KIF2A TREML1	4.12e-05	174	161	6	a3f4981b10afa9d41a1c66c7f98522a8a534f82b
ToppCell	PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CAMKK1 PTGIR GAS2L1 PTPRN KIF2A TREML1	4.12e-05	174	161	6	6cc108dde4b3f98a78a6040280f0d5e4aaa5bd75
ToppCell	PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CAMKK1 PTGIR GAS2L1 PTPRN KIF2A TREML1	4.12e-05	174	161	6	4b8bc5568e36031c8ecf001bb646809038c23919
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A WT1 ARHGEF17 PTGIR PDE8B CSPG4	4.25e-05	175	161	6	12f5fd83c7710fc0c77406f765d9cbd133433b8b
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega\|lymph-node_spleen / Manually curated celltypes from each tissue	PDE3A BEND2 CHST8 GAS2L1 PTPRN TREML1	4.25e-05	175	161	6	5ca3369ce2c2bb88ba097260195aecd67cec1a3a
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega-Megakaryocyte_early\|lymph-node_spleen / Manually curated celltypes from each tissue	PDE3A BEND2 CHST8 GAS2L1 PTPRN TREML1	4.39e-05	176	161	6	50fe3fd862dd6a6550ebb8c27f337cde468efedc
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A HTRA1 WNT4 GRIN2D RGS12 PCDH8	4.39e-05	176	161	6	23f930dac5247ea6d4124da33933d61ad6e089af
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A GRIN2D RGS12 KLHDC8A PCDH8 SDK1	4.53e-05	177	161	6	85e270b4a0b0da77ffe5987a099e827c02a4adf3
ToppCell	3'_v3-blood-Hematopoietic_progenitors\|blood / Manually curated celltypes from each tissue	WT1 MPDZ ARHGEF17 IGSF10 LIMCH1 NPW	4.53e-05	177	161	6	22c77077951889e63489abfabf90900655655c82
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	COL7A1 PKP4 PHRF1 MICALL2 FAM149B1 PC	4.67e-05	178	161	6	9d575902d3dbe33437c9d4200df093a741269803
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTRA1 WNT4 GRIN2D RGS12 PCDH8 SDK1	4.67e-05	178	161	6	3c973aac16988e88f5677d3d695dd772ccfd6570
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NTN3 WT1 GPC4 NHS NRG3 SDK1	4.67e-05	178	161	6	544379f5a6145429762258d426b876bb36c112f5
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK4 GAS2L1 CASKIN2 TREML1 UTY RASAL2	4.82e-05	179	161	6	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega\|lymph-node_spleen / Manually curated celltypes from each tissue	PDE3A BEND2 GAS2L1 PTPRN NPW TREML1	4.82e-05	179	161	6	4e0cf069bc47328eda753a4edc7e89b8915d52bb
Disease	Myasthenic Syndrome, Congenital, Fast-Channel	CHRND CHRNE	7.57e-05	3	149	2	C1837122
Disease	MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL	CHRND CHRNE	1.51e-04	4	149	2	C4084823
Disease	protein kinase C-binding protein NELL2 measurement	MATN2 ATXN2	1.51e-04	4	149	2	EFO_0802949
Disease	response to bevacizumab, Proteinuria	CAMKMT DNAH5	2.51e-04	5	149	2	EFO_0005943, HP_0000093
Disease	contactin-1 measurement	MUC19 CNTN1	3.75e-04	6	149	2	EFO_0020286
Disease	WILMS TUMOR 1	WT1 GPC4	3.75e-04	6	149	2	194070
Disease	Wilms tumor 1	WT1 GPC4	3.75e-04	6	149	2	cv:CN033288
Disease	Nephroblastoma	WT1 GPC4	6.95e-04	8	149	2	cv:C0027708
Disease	N-acetylcarnosine measurement	GABRR1 ATXN2	6.95e-04	8	149	2	EFO_0022101
Disease	chemotherapy-induced alopecia, methylcobalamin deficiency type cblE	CAMKMT DNAH5	6.95e-04	8	149	2	EFO_0005400, MONDO_0009354
Disease	Hereditary Wilms tumor	WT1 GPC4	6.95e-04	8	149	2	cv:C0677779
Disease	Kidney Wilms tumor	WT1 GPC4	6.95e-04	8	149	2	cv:CN305775
Disease	2-hydroxystearate measurement	MUC19 CNTN1	8.91e-04	9	149	2	EFO_0021059
Disease	migraine disorder, Headache	HTRA1 HJURP RNF213 RPRD2	9.62e-04	86	149	4	HP_0002315, MONDO_0005277
Disease	PR interval	DOCK4 KIF13B PDE3A MARK3 OBSCN WT1 CHRNE CASKIN2 ALPK3	9.62e-04	495	149	9	EFO_0004462
Disease	feeling nervous measurement	DPYD DNAH14 IRF2BPL MBD5	1.00e-03	87	149	4	EFO_0009597
Disease	platelet glycoprotein ib alpha chain measurement	CHRNE ATXN2	1.11e-03	10	149	2	EFO_0020645
Disease	left ventricular systolic function measurement	OBSCN ATXN2 ALPK3	1.44e-03	44	149	3	EFO_0008206
Disease	susceptibility to pneumonia measurement	TMPRSS13 DNAH14 TAP2 PCDH8	1.50e-03	97	149	4	EFO_0008410
Disease	tryptophan betaine measurement	DPYD IFT88	1.62e-03	12	149	2	EFO_0021017
Disease	risk-taking behaviour	DPYD MARK3 KLHL29 TTBK1 RP1L1 CAMKMT NRG3 ALDOA PC MTX1 SDK1	1.78e-03	764	149	11	EFO_0008579
Disease	Schizophrenia	DOCK4 CDK16 GABRR1 DPYD GRIN2D RGS12 PANK2 ATXN2 KIF2A NRG3 TAP2 PCDH8	1.80e-03	883	149	12	C0036341
Disease	developmental disorder of mental health (implicated_via_orthology)	GABRR1 GRIN2D RASAL2	1.96e-03	49	149	3	DOID:0060037 (implicated_via_orthology)
Disease	cognitive inhibition measurement	GFRA2 MICALL2 USH2A	2.08e-03	50	149	3	EFO_0007969
Disease	sitting height ratio	C10orf90 GFRA2 KLHL29	2.20e-03	51	149	3	EFO_0007118
Disease	glucose-dependent insulinotropic peptide measurement, glucose tolerance test	ARHGEF17 ST8SIA6	2.21e-03	14	149	2	EFO_0004307, EFO_0008464
Disease	vision disorder	SDK1 CNTN1	2.90e-03	16	149	2	MONDO_0021084
Disease	congenital myasthenic syndrome (implicated_via_orthology)	CHRND CHRNE	2.90e-03	16	149	2	DOID:3635 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	DPYD COL7A1 OBSCN WT1 GRIN2D NDUFS3 CHRND GLI1 NHS ALDOA TREML1 PCDH8 RASAL2	3.20e-03	1074	149	13	C0006142
Disease	Moyamoya Disease	HTRA1 RNF213	3.28e-03	17	149	2	C0026654
Disease	lysophosphatidylcholine 18:1 measurement	TAF4 NRG3	3.28e-03	17	149	2	EFO_0010360
Disease	Tinnitus	CAMKK1 WNT4 RASSF8 SDK1	4.34e-03	130	149	4	HP_0000360
Disease	coagulation factor measurement	FAM110A CNTN1	4.53e-03	20	149	2	EFO_0004634
Disease	hypertension	PDE3A RNF213 NDUFS3 KLHL29 TTBK1 ATXN2	4.79e-03	307	149	6	EFO_0000537
Disease	retinal vasculature measurement	CDCA3 PDE3A TTLL5 GFRA2 MXRA7 KLHL29 ATXN2 DNAH5	4.88e-03	517	149	8	EFO_0010554

Protein segments in the cluster

Peptide	Gene	Start	Entry
SQRPASPTAIRRIGS	PKP4	276	Q99569
VSGIAPATRSRATPQ	CHTF18	741	Q8WVB6
ARRLTTARRPPASSE	CHRND	411	Q07001
REIRGPAVPRLTSAE	SLC4A9	351	Q96Q91
FATPGVRPLRLTTAV	CLSTN3	601	Q9BQT9
PRLARRGVSSPVETR	BICD1	561	Q96G01
QASVPLRLTRGSRAP	CSPG4	1836	Q6UVK1
SVQLPAAPGSSVRAR	C19orf47	21	Q8N9M1
ALRRTVPPAVTGITF	ALDOA	256	P04075
PSRAIPATRRVVLGD	EIF4EBP1	11	Q13541
PTVEVAGLSPRTSRR	ALPK3	1201	Q96L96
SAAVPVRPRRGTAPA	CCNI2	71	Q6ZMN8
GRVEPILRRSSSESP	C1orf216	51	Q8TAB5
RAVTSIARALPGFPI	DPYD	776	Q12882
PVARSDRSAPVFTRA	ACSF3	36	Q4G176
VISATSSAGRLLPPR	AP5Z1	276	O43299
PVGASRSDPVTLNVR	CEACAM7	221	Q14002
PSRAERARSTPSPVL	DOT1L	891	Q8TEK3
ASPPRRASSVGLLLR	CHRNE	366	Q04844
RAASSRRVVPTAPEV	ARIH2OS	91	Q8N7S6
SLPDRGRPTVARVAT	ARIH2OS	111	Q8N7S6
RQAPTASGATIRLPA	ARIH2OS	151	Q8N7S6
GLRRRSTAPDIPSLV	ANKRD63	326	C9JTQ0
LARVADPRSPSAGIL	CDCA3	21	Q99618
AGRDVRVTPLPSLAS	HJURP	171	Q8NCD3
ILRRTGPSLSERPTS	RASSF8	76	Q8NHQ8
PPVRERSTRTAATSV	RBM15	591	Q96T37
RRVASALLSTRTSPP	RAB41	186	Q5JT25
ALGSRRAARVAPAEP	MTCL1	126	Q9Y4B5
RAARVAPAEPLSRAG	MTCL1	131	Q9Y4B5
PVSSPSRSLRSRQVA	MTCL1	1676	Q9Y4B5
RSPAGVSATLRRAQP	GLS	16	O94925
ITISSSRVTPRRGPV	KIAA1549	1096	Q9HCM3
TPRAQASREGLSRPT	MRNIP	266	Q6NTE8
IAGSPLTPRRVTEVR	RBL2	636	Q08999
PGATRSRAQSERALP	ARHGEF17	876	Q96PE2
TRLTTITRAPTRFPG	NRG3	156	P56975
PRVASVASSLAARGP	DCHS1	3051	Q96JQ0
ARVPRLPEQGSSSRA	PTPRN	291	Q16849
PTSLRAVLGAPDVAR	KLHL34	176	Q8N239
GARPLSTRVPRAAIV	MATN2	751	O00339
PSVSRTQPREVRRAA	MAP1S	531	Q66K74
TFARTVARSPVAPAR	MAFG	116	O15525
AVLGPVPLTRTSRTR	LYSMD1	201	Q96S90
AVAGRERPPRVATLS	GPANK1	316	O95872
TRRRSSQAGIPVRAP	NPW	101	Q8N729
PLPAGRISRSISESA	GPC4	346	O75487
TVTARVTQRAGPAAP	KCNK4	281	Q9NYG8
LPRRPARSVGSASVF	KCNK15	276	Q9H427
PRARAASVIPGSTSR	CAMKK1	46	Q8N5S9
ASVIPGSTSRLLPAR	CAMKK1	51	Q8N5S9
AAPRSPAVATESRRF	ATXN2	6	Q99700
DSAPGPALRVRTARS	EZHIP	316	Q86X51
RRAEARSQSLPAVTP	BEND2	766	Q8NDZ0
VRSPARPSESRLAPT	MICALL2	316	Q8IY33
VSPASVPGQRRLASR	IRF2BPL	661	Q9H1B7
RAATTRAAPGTTLVP	MUC19	6586	Q7Z5P9
GSPPRASSALLRVTV	PCDH1	256	Q08174
GRPPRSATAALSVRV	PCDH8	221	O95206
PLERSGVATRTPSRT	PDE3A	601	Q14432
SRASGPPSVARVRRA	PDE8B	56	O95263
TRRTVLTPSRRALPG	FAM110A	81	Q9BQ89
VVPTTSRLRPRAGRT	PHRF1	256	Q9P1Y6
VPAERSPRRRSISGT	RASAL2	6	Q9UJF2
PRRSAVSGTATQPRA	KDM4D	406	Q6B0I6
TRRRLTAVPDGIPAE	LINGO3	41	P0C6S8
RRVGPPVSLERRSSS	GLI1	531	P08151
LARPRGSPASALVLA	LRFN3	231	Q9BTN0
DPATRRTAPPRRTAS	PRR25	341	Q96S07
RLGSTSPRTLSVPVR	PRSS33	96	Q8NF86
RRPGRSALVRTSPSV	CASKIN2	831	Q8WXE0
RTTSVSARASIPPGV	DTX1	301	Q86Y01
AAAAAATPAVRTVPR	PABPC3	491	Q9H361
ARPVPEVGRAPTRSS	OBSCN	7251	Q5VST9
ERSPNGTSRRVPATT	NUP54	246	Q7Z3B4
EPLRRRASSASVPAV	PANK2	161	Q9BZ23
RVVLTRPSTAGDPRD	NTN3	221	O00634
RVASRAPALGPAVRA	PIK3R2	231	O00459
PSRDNRVVGSARARP	KIF2A	106	O00139
SAPRTAMRLPAGRAT	CCDC71	101	Q8IV32
ARAPPGSEARLSLAT	ICMT	6	O60725
DRRAVPARVPLGITT	GABRR1	306	P24046
TNRPPRSIVTRTGAA	IGSF10	2531	Q6WRI0
AVRTSHGRRPPITAK	IFT88	41	Q13099
VPFGVPASATVRRRA	HTRA1	91	Q92743
PASVSPDGTRVIPRR	DOCK4	1616	Q8N1I0
SGPSRARPSAALTVL	GFRA2	441	O00451
EAPTRAAPGELRSAR	CDK16	46	Q00536
LRSARGPLSSAPEIV	CDK16	56	Q00536
RGAQLSVPSPARRAR	GAS2L1	421	Q99501
RARSPAAPRLSRVSS	GAS2L1	476	Q99501
SRPLVRAPAAALASA	FH	11	P07954
SRAAPRASSVVPSRE	CCDC166	316	P0CW27
RASSVVPSREASRVP	CCDC166	321	P0CW27
ATSPPASVRILRAAA	GPR143	61	P51810
SQPPRIISSVRSGSR	CNTN1	906	Q12860
SVVLSSAPALRPRLG	C19orf73	106	Q9NVV2
RRVRDPTPIVASSPG	DNAH14	101	Q0VDD8
SPGRTRRAIAAVLSA	GPR142	271	Q7Z601
RTRPTGPREEATAAR	MAN1C1	111	Q9NR34
SAATPDRIRFPRGTA	MARK3	546	P27448
PVVPSRAATPRSVRN	MBD5	136	Q9P267
ARRPGTTTPARVDLQ	ATAT1	26	Q5SQI0
TSVPGARLSRLPLAR	POLE4	31	Q9NR33
ALPRLPTARAGVAVT	KLHDC8A	61	Q8IYD2
PREGSASVLTVRREP	COL7A1	581	Q02388
TISRSGIILRSPRPD	RPRD2	1406	Q5VT52
VVRGRTRESVPSAAP	SDK1	1266	Q7Z5N4
TSAARAPPQALRRRG	CABLES2	26	Q9BTV7
RQIAPRRPLAAAASS	FTMT	41	Q8N4E7
IRPSDIATVRTLGRP	DNAH5	3301	Q8TE73
RSRQTPSPDVVLRGS	LIMCH1	211	Q9UPQ0
LRGARVPVAPDSLSS	FAM149B1	446	Q96BN6
VSIQRATPARAPGTR	MTX1	441	Q13505
APGSPFRVRRVRASE	KIF13B	1641	Q9NQT8
RRVSVSPGQASPLVT	PUSL1	196	Q8N0Z8
SGIRATLTPTVLAPR	TAF4	421	O00268
IPRSGTPVSIRSNRS	USH2A	5106	O75445
LTRVSSVSQPGVRPA	UTY	496	O14607
ASPRRIRAEGVPASA	SPATA2L	331	Q8IUW3
PAVSSRTRSRSLPRE	NHS	496	Q6T4R5
RESAGADTRPTVRPR	NDUFS3	36	O75489
SALRGTRAPPSAVAR	PYURF	11	Q96I23
AVRSPRRREAPAPSS	FBXL22	121	Q6P050
GTPAALRTLRSPATA	ST8SIA6	46	P61647
ALVAGASRAPPARVA	TAP2	81	Q03519
RPLARASRPSGAVSE	NUAK2	531	Q9H093
RPERSLATGQPATSR	PRR12	1766	Q9ULL5
TTRGPVVSAPLGAAR	CAMKMT	26	Q7Z624
PRSTADTRPRATVIT	CSNK1G2-AS1	6	Q8NCQ2
PTERVTRDLSSGAPR	CHST8	71	Q9H2A9
AVRTVALNAPSRSRP	C12orf50	341	Q8NA57
ASPSRLSVARSSRIP	CLASP2	506	O75122
LSVARSSRIPRPSVS	CLASP2	511	O75122
TITARRVGPPARALV	C10orf90	141	Q96M02
RASDSLSARPSVRPL	ATP11C	1106	Q8NB49
EVSPSRTIRAPAVRT	PKP3	236	Q9Y446
VPSRSSSALRTRVPQ	RNF213	2106	Q63HN8
VVPRRQPSRAATAAT	ZNF48	251	Q96MX3
SGRAAATRSRIPRPI	TTBK1	1146	Q5TCY1
LVRATPVGAVPIRSS	TMPRSS13	121	Q9BYE2
PIRSSPARSAPATRA	TMPRSS13	131	Q9BYE2
PARSAPATRATRESP	TMPRSS13	136	Q9BYE2
RRPLVASVGLNVPAS	UQCRFS1	61	P47985
SPPRVRSVEVARGRA	RGS12	16	O14924
SILTATAVPGPSLRR	SEMA4G	11	Q9NTN9
ARGSLPQLVSPIVSR	MPDZ	221	O75970
RRAVSEVARPASTPP	SRCIN1	1056	Q9C0H9
RVPLSFGVRSVTTPR	RP1L1	71	Q8IWN7
SVLRNSRPRPASLGT	SARG	521	Q9BW04
GILSARRPARPSAFA	PTGIR	36	P43119
RRPARPSAFAVLVTG	PTGIR	41	P43119
EVPSARPRRAVTLRS	SFMBT2	751	Q5VUG0
RPRRAVTLRSGSEPV	SFMBT2	756	Q5VUG0
PAASRPAALPTSRRV	USP49	221	Q70CQ1
RRVPGVAPTLVRSAS	WT1	301	P19544
APAPSRGSVQVALSR	SCART1	486	Q4G0T1
VLPSNARGPILSRST	SPRY1	101	O43609
SLLVPRGPSSREIAS	ZC3H12B	161	Q5HYM0
RTARSLRPGPAAAAA	TMEM65	11	Q6PI78
PPEVASLADRASRAR	ZSWIM8	1336	A7E2V4
PRRVGSSRALVPRNA	WNT4	246	P56705
APGRISTSPTLRRLR	PLEKHG7	41	Q6ZR37
LAPQGVRTTLSVPSR	SNAPC4	1381	Q5SXM2
RSVAARSGPFAPVLS	UQCRFS1P1	11	P0C7P4
RDGQVPPASRSRSVL	PLBD2	51	Q8NHP8
STRERVTSPVRAAGP	nan	116	Q8N1Y9
LEREPGRPRSSVTVS	ZSCAN29	96	Q8IWY8
PLVSSAVDRRAPAGR	TREML1	61	Q86YW5
SPSLARRASVRPGEL	VGLL1	116	Q99990
IPQTRSDIPAGARRS	ZNF619	31	Q8N2I2
IRRTSTAPAASPNVR	PC	16	P11498
GIINRSSASAPPTLR	TTLL5	1066	Q6EMB2
RRLSPQTGIPRTTAV	nan	296	Q8N7P7
TPRTRPRLSAGVAEV	KLHL29	571	Q96CT2
LVRRGAAASPEPARA	MXRA7	26	P84157
AARLGPAVAAAVRSP	GRIN2D	66	O15399